On April 25, 2024, OncoCyte Corporation closed the transaction. The transaction included participation from 21 investors pursuant to Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.76 USD | -0.36% | +10.84% | +10.40% |
Apr. 25 | OncoCyte Corporation announced that it has received $15.807655 million in funding | CI |
Apr. 16 | Broadwood Capital, Inc. Engages with OncoCyte Corporation | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.40% | 37.02M | |
+10.44% | 106B | |
+0.82% | 104B | |
+6.72% | 23.25B | |
-13.89% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-10.98% | 16.99B | |
+8.67% | 14.26B | |
+41.08% | 12.76B |
- Stock Market
- Equities
- OCX Stock
- News OncoCyte Corporation
- OncoCyte Corporation announced that it has received $15.807655 million in funding